Clinical Trial Results: Low-dose Naltrexone for Bladder Pain Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of low-dose naltrexone for bladder pain syndrome and interstitial cystitis was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Pain Syndrome
• Interstitial Cystitis

Drugs mentioned

• Low Dose Naltrexone (naltrexone)

Snippet

Sponsor: Stanford University | Conditions: Bladder Pain Syndrome, Interstitial Cystitis | Phase 2 | Status: TERMINATED | Results posted: 2026-07-10